copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
4P Pharma, Translating Science to Medicine for Patients Established in 2014, 4P-Pharma is a clinical stage biotech company dedicated to addressing serious diseases with significant unmet medical needs Our goal is to bring first-in-class therapies to patients swiftly
4P-Pharma at CPHI Frankfurt 2025 We’re excited to announce that 4P-Pharma will be attending CPHI Frankfurt 2025 🇩🇪 Our Business Development team, Roselina Lam, Anne-Claire Gaudiez and our CMC expert, Frédéric Lallemand, will be on site to meet partners and explore new opportunities to accelerate access to treatments for patients
4P-Pharma Announces Total Capital of €15 Million Successfully Secured . . . With this funding, 4P-pharma’s shareholders renew their confidence in the company’s drug regeneration model for untreated serious diseases They welcome the entry of Phase 2 clinical development of the two first 4P-Pharma SPVs, underlying the robust potential of the company’s business model
4Moving Biotech Welcomes Luc Boblet as Chief Executive Officer - 4P Pharma 4Moving Biotech, a subsidiary of 4P-Pharma, is pleased to announce Luc Boblet’s appointment as its new Chief Executive Officer Luc is an experienced and passionate biotech entrepreneur with two decades of experience His established track record speaks highly about his leadership and vision
4Living Biotech and Sanofi sign a clinical collaboration agreement - 4P . . . Pascal Rigaudy, Global Head, Transplant Brands at Sanofi, mentioned that “Through its collaboration with 4P-Pharma, Sanofi is delighted to continue to advance the fight against COVID-19 and reinforce its partnership approach to promote the research and biotech sector in France, […]
4Living Biotech obtains clinical trial authorizations in Europe to . . . 4Living Biotech, a biotechnology company and subsidiary of 4P-Pharma, specializing in the treatment of respiratory infections, has received approval from the French National Agency for Medicinal Products (ANSM) and two other European agencies to initiate a Phase IIb clinical trial of LEONARDO in patients with acute respiratory failure
4P-Pharma’s New R D Booster We’re thrilled to announce the launch of Dev4All, 4P-Pharma’s new R D booster With a strong biotech foundation and over ten years of experience, we turn innovative ideas into clinical-stage candidates
AI biotech Oncocross partners with 4P-Pharma, a France based biotech. Dr Yirang Kim, CEO of Oncocross, mentioned that “we are very excited about this collaboration with 4P-Pharma, where we can put together our AI platform technology and 4P-Pharma’s R D expertise to tackle and overcome this rare disease ”